Search

Your search keyword '"Yoh Matsuoka"' showing total 270 results

Search Constraints

Start Over You searched for: Author "Yoh Matsuoka" Remove constraint Author: "Yoh Matsuoka"
270 results on '"Yoh Matsuoka"'

Search Results

1. Treatment‐related neuroendocrine prostate cancer with BRCA2 germline mutation treated with olaparib

2. A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)

Catalog

Books, media, physical & digital resources

3. Defining Tumour Shape Irregularity for Preoperative Risk Stratification of Clinically Localised Renal Cell Carcinoma

4. Improving Kidney Tumor Classification With Multi-Modal Medical Images Recovered Partially by Conditional CycleGAN

5. Urinary Stones Segmentation in Abdominal X-Ray Images Using Cascaded U-Net Pipeline With Stone-Embedding Augmentation and Lesion-Size Reweighting Approach

6. Succinate dehydrogenase‐deficient malignant paraganglioma complicated by succinate dehydrogenase‐deficient renal cell carcinoma

7. Improvement of Urinary Stone Segmentation Using GAN-Based Urinary Stones Inpainting Augmentation

8. Late recurrence of late-onset large cell calcifying Sertoli tumor successfully managed by early surgical intervention

9. Computer-aided diagnosis with a convolutional neural network algorithm for automated detection of urinary tract stones on plain X-ray

10. Nonmetastatic castration‐resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy

11. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study

12. Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab

13. Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma

14. Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study

15. New head-mounted display system applied to endoscopic management of upper urinary tract carcinomas

16. Patient's Self-monitoring of Transurethral Surgical Images Using a Head-mounted Display

17. The role of multimodal salvage therapy in the management of recurrent adrenocortical carcinoma

18. Patterns of recurrence in genuine and induced oligometastatic castration‐resistant prostate cancer treated with progressive site‐directed therapy

19. Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: Immortal time bias-corrected analysis

20. Predictive ability of prebiopsy magnetic resonance imaging and biopsy for side‐specific negative lymph node metastasis at radical prostatectomy

21. Pretreatment Hemoglobin Levels and Platelet-to-Lymphocyte Ratio Predict Survival Benefit from Pembrolizumab in Advanced Urothelial Carcinoma

23. Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society

24. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study

25. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer

26. Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in <scp>Castration‐Resistant</scp> Prostate Cancer

33. Outcomes of gasless laparoendoscopic single‐port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique

34. Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab

35. METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer

36. A case of recurrent thrombocytopenia involving divergent immune-related mechanisms associated with pembrolizumab

37. Longitudinal changes in patient‐reported outcomes after artificial urinary sphincter implantation

38. Feasibility and outcomes of selective tetramodal bladder‐preservation therapy in elderly patients with muscle‐invasive bladder cancer

39. Nonmetastatic castration‐resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy

40. Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response

41. MP59-06 LONGITUDINAL CHANGE OF RENAL PARENCHYMAL VOLUME PRESERVED AFTER PARTIAL NEPHRECTOMY IN PATIENTS WITH PREEXISTING CHRONIC KIDNEY DISEASE

42. MP14-11 SIGNIFICANCE OF RADIOLOGIC INFILTRATIVE FEATURE OF PRIMARY RENAL TUMOR IN PREDICTING PATIENT SURVIVAL IN METASTATIC RENAL CELL CARCINOMA

43. Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients

44. Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progression

45. Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab

46. Infiltrative tumor interface with normal renal parenchyma in locally advanced renal cell carcinoma: Clinical relevance and pathological implications

47. Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018

48. Computer-aided Diagnosis with a Convolutional Neural Network Algorithm for Automated Detection of Urinary Tract Stones on Plain X-ray

49. Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patients

50. Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab